Vibrio cholerae O139 (173 strains) and O1 (221 strains) were tested for their in vitro susceptibilities to 39 antimicrobial agents. Both O139 and O1 strains were highly susceptible to azithromycin, cephems, minocycline, penems, and newer fluoroquinolones. O139 strains (94.8%), O1 Indian El Tor strains (97%), and Bangladeshi El Tor strains (50%) were highly resistant to streptomycin, sulfamethoxazole, and trimethoprim and moderately resistant to chloramphenicol and furazolidone, in sharp contrast to O1 Peruvian El Tor and O1 classical strains. Some Bangladeshi El Tor strains (43.3%) showed tetracycline resistance as well.
Vibrio cholerae O1 biotype El Tor, the causative agent of the seventh cholera pandemic (6) , was first recorded in 1961 in Indonesia and continues to possess the capacity of causing cholera endemics. For instance, in 1991, El Tor strains appeared in South and Central America, starting in Peru, where no large cholera endemics had been recorded in this century (31, 32) . In 1982, the classical biotype of V. cholerae O1 (the causative agent of the previous cholera pandemics) reappeared in Bangladesh and continues to persist (16) . Large explosive cholera endemics due to V. cholerae non-O1 strains that elaborate cholera toxin occurred in India and Bangladesh from October 1992 (1, 10, 24, 33) . V. cholerae O139 Bengal, which is currently classified as the epidemic non-O1 strain, has spread to neighboring countries (e.g., Thailand [4] , Pakistan [7] , and Singapore [5] ), and imported cases associated with V. cholerae O139 have now been reported from the United States (28) , Japan (17) , and Switzerland (3) .
In addition to being resistant to streptomycin (24) and the vibriostatic agent O/129 (1), V. cholerae O139 strains are usually resistant to sulfamethoxazole-trimethoprim (co-trimoxazole) (1, 24, 28) and to furazolidone (24) ; the last two are often recommended for the treatment of cholera (9, 23) . Moreover, most of the V. cholerae O1 El Tor strains in Bangladesh are resistant to tetracycline (1) . In this study, we investigated the in vitro susceptibilities of V. cholerae O139 strains to 39 antimicrobial agents and compared them with those obtained for V. cholerae O1 strains belonging to the classical and El Tor biotypes.
All V. cholerae strains used in this study were of clinical origin. The 173 O139 strains examined were isolated during the period 1992 to 1993 and included 134 strains from India, 30 from Bangladesh, and 9 from Thailand. Of the 72 O1 classical strains examined, 66 were isolated from 1960 to 1965 in India while 6 were isolated in 1982 in Bangladesh. A total of 149 O1 El Tor strains examined in this study included 67 from India isolated from 1985 to 1990, 52 from Peru isolated in 1991, and 30 from Bangladesh isolated in 1994. Isolates were stored frozen at Ϫ80ЊC.
The antimicrobial agents were gifts from their manufacturers. Amoxicillin was used in combination with clavulanic acid (a ␤-lactamase inhibitor). Penems used were FCE22101 (8) and SY5555 (11a) (alternatively named SUN5555 [21] , ALP201 [2a] , and WY-49,605). Azithromycin is a 15-membered ring macrolide (25) . Newer quinolones included BAYy3118 (2) and DU6859a (27) . Furazolidone, 3-(5-nitrofurfurylideneamino)-2-oxazolidinone, was also used. Sulfamethoxazole and trimethoprim were used alone and in combination at ratios of 5:1 (as in the combination drug) and 20:1 (the expected ratio in the human body). O/129 (2,4-diamino-6,7-diisopropylpteridine phosphate) was purchased from Sigma Chemical, St. Louis, Mo.
Susceptibility testing of bacterial strains was done by the agar dilution method with Mueller-Hinton agar (Difco Laboratories, Detroit, Mich.) according to standard procedures (14, 26) . The final concentrations of antimicrobial agents were from 0.004 to 128 g/ml. The test bacteria were grown for 18 h at 37ЊC with agitation in L broth (18) and diluted to approximately 10 6 CFU/ml. Aliquots of the bacterial suspension (approximately 10 4 CFU per spot) were inoculated on the surface of antimicrobial agent-containing agar plates. Incubation was for 20 h at 37ЊC. The MIC was determined as previously described (14, 26) . Escherichia coli NIHJ JC-2 was used as a reference strain for quality control (12, 14, 19, 20, 22) . When the susceptibility to sulfamethoxazole or trimethoprim was tested, Mueller-Hinton agar supplemented with 7.5% (vol/vol) defibrinated horse blood (frozen and thawed) was also used, in addition to Mueller-Hinton agar alone (13) .
The MICs of the antimicrobial agents against clinical isolates of O139 are summarized in Table 1 . Among antimicrobial agents tested, the newer quinolones (norfloxacin, ofloxacin, tosufloxacin, ciprofloxacin, sparfloxacin, BAYy3118, and DU6859a) showed the greatest activity (MICs, Յ0.06 g/ml). Six (I-2, I-7, I-14, I-15, I-64, and I-72) of the 173 O139 strains (3.5%) were resistant to ampicillin (MIC, Ն256 g/ml), tetracycline (MIC, 8 to 16 g/ml), chloramphenicol (MIC, 32 g/ml), kanamycin (MIC, Ն256 g/ml), and gentamicin (MIC, 128 to Ն256 g/ ml). With the exception of one strain (B20), the remaining 172 strains were all highly resistant to streptomycin (MIC, Ն64 g/ml), sulfamethoxazole (MIC, Ն256 g/ml), trimethoprim (MIC, Ն128 g/ml), and O/129 (MIC, Ն256 g/ml).
The MICs at which 50% of the isolates were inhibited (MIC 50 s) and MIC 90 s of the antimicrobial agents for O1 clinical isolates were very similar to the MIC 50 s and MIC 90 s for O139 (Table 1) , except those of tetracycline, chloramphenicol, furazolidone, streptomycin, sulfamethoxazole, trimethoprim, and O/129. One strain (0.5%) belonging to the classical biotype was resistant to ampicillin (MIC, 64 g/ml), tetracycline (MIC, 8 g/ml), chloramphenicol (MIC, 32 g/ml), kanamycin (MIC, Ն256 g/ml), streptomycin (MIC, Ն256 g/ml), sulfamethoxazole (MIC, Ն256 g/ml), trimethoprim (MIC, Ն256 g/ml), and O/129 (MIC, Ն256 g/ml).
Subtypes of O139 and O1 strains showing different susceptibility patterns (with respect to tetracycline, chloramphenicol, furazolidone, streptomycin, sulfamethoxazole, trimethoprim, and O/129) are summarized in The major susceptibility pattern of O1 Peruvian El Tor strains (98.1%) was distinctly different from the major susceptibility pattern of O1 Indian El Tor strains (97%) (VC MAR1) but was quite similar to minor pattern B of O1 Indian El Tor strains (1.5%). The major susceptibility pattern of O1 Peruvian El Tor strains (98.1%) also resembled the major susceptibility pattern of O1 classical strains (94.4%).
Plasmids of V. cholerae strains were isolated and electrophoresed in 0.3 or 0.7% agarose with reference plasmid DNAs of known molecular size (including the 94.5-kb NR1 plasmid [30] ) as previously described (15, 34) . Six strains of V. cholerae O139 (I-2, I-7, I-14, I-15, I-64, and I-72) had plasmids with a molecular size of ca. 200 kb. These 200-kb plasmids encoded resistance to ampicillin, tetracycline, chloramphenicol, kanamycin, gentamicin, sulfamethoxazole, trimethoprim, and O/129 (34a). In contrast, two O139 strains and two O1 Indian El Tor strains with the VC MAR1 phenotype (susceptible to tetracycline, ampicillin, and gentamicin) and six O1 Bangladeshi El Tor strains with the VC MAR2 phenotype tested had no detectable plasmids. Thus far, no correlation has been found between plasmids and the VC MAR phenotypes.
The incidence of tetracycline-resistant O1 El Tor strains in Bangladesh was 1.9% (number of strains tested, 317) in 1990, 7.6% (number of strains tested, 1,377) in 1991, 61.1% (number of strains tested, 1,221) in 1992, and 85.4% (number of strains tested, 669) in 1993; the data were obtained with antibiotic discs. In contrast, in India, tetracycline resistance is not frequently found in O1 El Tor strains (data not shown). Thus, there are apparent differences in tetracycline susceptibility which are related to the geographic origin within the Asian subcontinent. The tetracycline-resistant strains found in this study were all susceptible to minocycline (MIC, 0.06 to 0.25 g/ml).
Cefoperazone resistance was observed for some strains of V. cholerae O139 (2.3%) (MIC, 8 to 16 g/ml [ Table 1 ]) and V. cholerae O1 (1.4%) (MIC, 8 to 128 g/ml). V. cholerae O139 and O1 also tended to be resistant to nalidixic acid, with resistance rates of 4% (MIC, 4 to 16 g/ml) for O139 (Table 1 ) and 1.4% (MIC, 4 to 8 g/ml) for O1. Such resistant strains may have been selected by use of the related antimicrobial agents.
Azithromycin was eightfold more active against both O139 and O1 strains than was erythromycin. Since erythromycin has a good safety record (29) and azithromycin has also been shown to be safe in children (11) , azithromycin would be a potential, attractive chemotherapeutic agent of choice in treatment of V. cholerae O139 and O1 infections. Newer quinolones were extremely active against both O139 and O1 strains. However, newer quinolones have not usually been recommended in the treatment of cholera in the pediatric age group. c One multiple-drug-resistant strain (1.4%; described in the text) was omitted. The MICs (in micrograms per milliliter) of chloramphenicol, furazolidone, streptomycin, sulfamethoxazole, trimethoprim, and O/129 for this strain were 32, 0.25, Ն256, Ն256, Ն256, and Ն256, respectively; the MIC of furazolidone was similar to the MIC of furazolidone for the major type (or minor types B and C). 
